Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 440 participants.
Also called NCT06814145
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 440 participants
- Sponsor
- Registry
-
NCT06814145 -
U1111-1309-2142 -
2024-515773-99-00
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Belgium, Canada, France, Germany, Israel, Italy, Mexico, Poland, Spain, Sweden, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06814145. Randomized; no masking; primary purpose treatment. Start 2025-04-16 (actual); primary completion 2035-08-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
- Acronym
- HARMONIZE
- Condition
- Hypertension, Pulmonary
- Intervention (Biological)
- Sotatercept
- Lead sponsor
- Merck Sharp & Dohme LLC
Record details
- Record id
cardio:ct-nct06814145- Content hash
7527f97b8a76353350380c492159ef2d83fbd9a1f24c677f62c70c8570cee009